TPCHRF - Round 6 - Pre-clinical assessment of poly-arginine R18 peptide as neuroprotective agent for perinatal hypoxic-ischaemic encephalopathy (HIE)

StatusActive
Effective start/end date1/07/1830/06/20

Funding

  • WA Department of Health